BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, June 4, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 9, 2020
View Archived Issues
Positive interim phase III data released for lenzilumab in hospitalized patients with COVID-19
Read More
FDA approves Brilinta to reduce the risk of stroke in acute ischemic stroke or high-risk TIA
Read More
Phase II study of ABTL-0812 in pancreatic cancer approved in the U.S. and Spain
Read More
Spanish researchers patent new HDAC6 inhibitors
Read More
Rottapharm Biotech divulges protein kinase inhibitors
Read More
Janssen Biotech presents DHODH inhibitors
Read More
Seres Therapeutics initiates phase Ib study of SER-301 in ulcerative colitis
Read More
Azeria Therapeutics synthesizes new SGK inhibitors
Read More
Synerkine Pharma discloses new IL-13-comprising fusion proteins
Read More
PARP inhibition can help out tumor cells
Read More
SASH3 mutations associated with a new X-linked combined immunodeficiency
Read More
Revving up cisplatin by targeting Rev7
Read More
HIP1R variants linked to a recessive, progressive, neurologic disorder
Read More
USP48 gene tied to nonsyndromic hereditary hearing loss
Read More
Organoids enable tumor genotype-phenotype mapping
Read More
CaMK4 as potential target to slow cyst growth in PKD
Read More
SARS-CoV-2 spike proteins directly activate the APC, which can be blocked by factor D inhibition
Read More
New markers identified for kidney disease and its prognosis
Read More
FDA approves Sesquient to treat status epilepticus in adult and pediatric patients
Read More
Phase III trial of Nefecon in primary IgAN meets key endpoints
Read More
7 Hills Pharma begins first-in-human study of integrin activator 7HP-349
Read More
Phase III interim analysis shows COVID-19 vaccine efficacy rate above 90% with BNT-162b2
Read More
